BRIANNE HARPER: Open Payments
NPI 1700430261 · GRAND JUNCTION, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,313 in 63 payments from 17 companies in 2025. Trend: 2023 $922 · 2024 $1,423 · 2025 $1,313
Food & beverage: $1,079Education: $235
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $322 |
| ABBVIE INC. | 14 | $188 |
| GENZYME CORPORATION | 8 | $165 |
| Novartis Pharmaceuticals Corporation | 5 | $106 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $102 |
| Lilly USA, LLC | 3 | $73 |
| UCB, Inc. | 3 | $64 |
| Biofrontera Inc. | 3 | $51 |
| LEO Pharma Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, RINVOQ, Bimzelx, COSENTYX, EBGLYSS, LIBTAYO.
Industry payments across CO — which companies pay providers there.
